Legend Biotech (LEGN) Tax Provisions (2022 - 2025)
Legend Biotech (LEGN) reported Tax Provisions of -$11.2 million for Q4 2025, up 21.13% on a YoY basis from -$9.2 million in Q4 2024, and down 1718.18% quarter-over-quarter from -$616000.0 in Q3 2025.
Legend Biotech (LEGN) Tax Provisions (2022 - 2025) Analysis & Trends
Legend Biotech has reported Tax Provisions for 4 years, with the latest figure at -$11.2 million in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 21.13% year-over-year to -$11.2 million; the trailing twelve-month figure through Dec 2025 stood at -$14.2 million (up 24.82% YoY), and the FY2025 full-year result was -$14.2 million, up 24.87% from the prior year.
- Tax Provisions for Q4 2025 stood at -$11.2 million, down from -$616000.0 in the prior quarter.
- The five-year high for Tax Provisions was $288000.0 in Q3 2023, with the low at -$14.2 million in Q4 2024.
- Historically, Tax Provisions has averaged -$2.1 million across 4 years, with a median of -$194500.0 in 2022.
- Annual changes were most pronounced in 2023 — Tax Provisions jumped 289.47% — and 2024, when it tumbled 712236.41%.
- Legend Biotech's Tax Provisions stood at -$153000.0 in 2022, then surged by 101.3% to $1994.0 in 2023, then plunged by 712236.41% to -$14.2 million in 2024, then grew by 21.13% to -$11.2 million in 2025.
- The last three Tax Provisions figures came in at -$11.2 million (Q4 2025), -$616000.0 (Q3 2025), and -$582000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 104.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.20 Mn |
| Sep 30, 2025 | -616,000.00 |
| Jun 30, 2025 | -582,000.00 |
| Mar 31, 2025 | -1.79 Mn |
| Dec 31, 2024 | -14.20 Mn |
| Sep 30, 2024 | -4.44 Mn |
| Jun 30, 2024 | -226,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 1,994.00 |
| Sep 30, 2023 | 288,000.00 |
| Jun 30, 2023 | -290,000.00 |
| Mar 31, 2023 | -128,000.00 |
| Dec 31, 2022 | -153,000.00 |
| Sep 30, 2022 | -152,000.00 |
| Jun 30, 2022 | -157,000.00 |
| Mar 31, 2022 | -163,000.00 |